Drug of choice for initial management of severe malaria (given by intravenous or intramuscular injection).
Oral preparation given as part of combination therapy to treat uncomplicated malaria.
Well-tolerated. Type 1 hypersensitivity reported rarely (< 1:10 000 patients)
Average serum half life: Less than 1 hour